uniQure NV (QURE US)

Analysis

Health Care • Netherlands

uniQure N.V. delivers gene therapy with single treatments for curative results. The Company develops a modular platform to bring new disease modifying therapies to patients with severe genetic diseases, as well as offers ongoing clinical programs in hemophilia B and pre-clinical proof-of-concept in Huntington's disease.

Refresh

Company Event • 09 Nov 2026 21:30 • Upcoming

Add To Calendar

Q3 2026

Company Event • 29 Sep 2026 20:30 • Latest

Study update

Company Event • 29 Jul 2026 20:30

Q2 2026

Company Event • 05 May 2026 20:30

Q1 2026

Company Event • 27 Apr 2026 20:00 • Upcoming